Catalyst Pharmaceuticals Current Ratio 2006-2018 | CPRX

Catalyst Pharmaceuticals current ratio from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Catalyst Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $0.06B $0.00B 18.01
2018-06-30 $0.07B $0.00B 22.42
2018-03-31 $0.08B $0.00B 28.90
2017-12-31 $0.09B $0.00B 19.97
2017-09-30 $0.03B $0.00B 12.57
2017-06-30 $0.04B $0.00B 19.43
2017-03-31 $0.04B $0.00B 19.66
2016-12-31 $0.04B $0.00B 19.79
2016-09-30 $0.05B $0.00B 22.58
2016-06-30 $0.05B $0.00B 21.11
2016-03-31 $0.05B $0.00B 20.08
2015-12-31 $0.06B $0.00B 17.41
2015-09-30 $0.06B $0.00B 26.97
2015-06-30 $0.07B $0.00B 26.74
2015-03-31 $0.08B $0.01B 12.99
2014-12-31 $0.04B $0.01B 7.49
2014-09-30 $0.05B $0.01B 7.71
2014-06-30 $0.05B $0.00B 19.39
2014-03-31 $0.02B $0.00B 9.10
2013-12-31 $0.03B $0.00B 11.83
2013-09-30 $0.03B $0.00B 9.51
2013-06-30 $0.01B $0.00B 7.62
2013-03-31 $0.01B $0.00B 14.65
2012-12-31 $0.02B $0.00B 10.16
2012-09-30 $0.01B $0.00B 16.04
2012-06-30 $0.01B $0.00B 11.35
2012-03-31 $0.01B $0.00B 5.65
2011-12-31 $0.01B $0.00B 7.47
2011-09-30 $0.00B $0.00B 10.10
2011-06-30 $0.01B $0.00B 8.50
2011-03-31 $0.01B $0.00B 8.23
2010-12-31 $0.01B $0.00B 19.32
2010-09-30 $0.01B $0.00B 16.05
2010-06-30 $0.01B $0.00B 12.96
2010-03-31 $0.01B $0.00B 20.81
2009-12-31 $0.01B $0.00B 26.81
2009-09-30 $0.01B $0.00B 18.80
2009-06-30 $0.01B $0.00B 13.57
2009-03-31 $0.01B $0.00B 5.95
2008-12-31 $0.01B $0.00B 8.33
2008-09-30 $0.02B $0.00B 12.47
2008-06-30 $0.01B $0.00B 18.10
2008-03-31 $0.02B $0.00B 35.02
2007-12-31 $0.02B $0.00B 54.51
2007-09-30 $0.02B $0.00B 43.07
2007-06-30 $0.02B $0.00B 43.43
2007-03-31 $0.02B $0.00B 36.88
2006-12-31 $0.02B $0.00B 26.64
2006-09-30 $0.00B $0.00B 4.38
2006-06-30 $0.00B $0.00B 0.00
2006-03-31 $0.00B $0.00B 0.00
2005-09-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.316B $0.001B
CATALYST PHARMACEUTICAL PARTNERS, INC. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from Brookhaven National Laboratory an exclusive worldwide license for Brookhaven's patent portfolio in the US relating to the right to use vigabatrin to treat a wide variety of substance addictions and obsessive compulsive disorders. Catalyst has also been granted rights to Brookhaven's vigabatrin-related foreign patents or patents pending worldwide. The Company's initial product candidate based on vigabatrin is CPP-109. CPP-109 has been granted `Fast Track` status by the U.S. Food & Drug Administration for the treatment of cocaine addiction. This indicates that the FDA has recognized that CPP-109 is intended for the treatment of a serious or life-threatening condition for which there is no effective treatment and which demonstrates the potential to address unmet medical needs.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $46.810B 31.14
Takeda Pharmaceutical (TAK) Japan $33.231B 12.30
Grifols (GRFS) Spain $13.208B 16.01
Ionis Pharmaceuticals (IONS) United States $11.005B 34.13
Neurocrine Biosciences (NBIX) United States $7.703B 498.88
Jazz Pharmaceuticals (JAZZ) Ireland $7.671B 10.98
Sage Therapeutics (SAGE) United States $7.388B 0.00
Tilray (TLRY) United States $6.730B 0.00
Catalent (CTLT) United States $6.200B 25.96
Nektar Therapeutics (NKTR) United States $6.081B 9.70
United Therapeutics (UTHR) United States $5.196B 8.84
FibroGen (FGEN) United States $4.764B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.283B 22.76
Taro Pharmaceutical Industries (TARO) Israel $4.238B 13.64
Zogenix (ZGNX) United States $2.224B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.215B 0.00
Portola Pharmaceuticals (PTLA) United States $2.208B 0.00
PTC Therapeutics (PTCT) United States $2.149B 0.00
Aerie Pharmaceuticals (AERI) United States $2.140B 0.00
USANA Health Sciences (USNA) United States $2.129B 17.87
Ironwood Pharmaceuticals (IRWD) United States $2.072B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.994B 24.83
Endo (ENDP) Ireland $1.928B 2.97
Heron Therapeutics (HRTX) United States $1.908B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.779B 0.00
Xencor (XNCR) United States $1.712B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.625B 140.79
Corcept Therapeutics (CORT) United States $1.412B 20.52
Theravance Biopharma (TBPH) Cayman Islands $1.338B 0.00
TherapeuticsMD (TXMD) United States $1.334B 0.00
Esperion Therapeutics (ESPR) United States $1.302B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.158B 0.00
Tricida (TCDA) United States $1.091B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.895B 0.00
Radius Health (RDUS) United States $0.860B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.612B 0.00
Odonate Therapeutics (ODT) United States $0.611B 0.00
Collegium Pharmaceutical (COLL) United States $0.587B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.573B 0.00
Forty Seven (FTSV) United States $0.559B 0.00
ChemoCentryx (CCXI) United States $0.545B 0.00
GlycoMimetics (GLYC) United States $0.541B 0.00
Dermira (DERM) United States $0.531B 0.00
ArQule (ARQL) United States $0.521B 0.00
Siga Technologies (SIGA) United States $0.490B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.486B 28.64
Akebia Therapeutics (AKBA) United States $0.466B 0.00
KalVista Pharmaceuticals (KALV) United States $0.454B 0.00
Flexion Therapeutics (FLXN) United States $0.453B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.442B 0.00
Translate Bio (TBIO) United States $0.434B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.430B 0.00
TCR2 THERAPTCS (TCRR) United States $0.419B 0.00
Concert Pharmaceuticals (CNCE) United States $0.395B 0.00
ImmunoGen (IMGN) United States $0.387B 0.00
Aptorum Group (APM) China $0.378B 0.00
OptiNose (OPTN) United States $0.376B 0.00
Minerva Neurosciences (NERV) United States $0.329B 0.00
Karyopharm Therapeutics (KPTI) United States $0.323B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.316B 0.00
CASI Pharmaceuticals (CASI) United States $0.314B 0.00
Lannett Co Inc (LCI) United States $0.310B 2.88
HARPOON THERAPT (HARP) United States $0.299B 0.00
Mast Therapeutics (SVRA) United States $0.292B 0.00
Majesco Entertainment (PTE) United States $0.283B 0.00
Immune Design (IMDZ) United States $0.282B 0.00
Aclaris Therapeutics (ACRS) United States $0.278B 0.00
Xeris Pharmaceuticals (XERS) United States $0.277B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.274B 10.14
MARKER THERAPEUTICS, INC (MRKR) United States $0.257B 0.00
Calithera Biosciences (CALA) United States $0.256B 0.00
Dova Pharmaceuticals (DOVA) United States $0.253B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.250B 0.00
Affimed (AFMD) Germany $0.245B 0.00
Tyme Technologies (TYME) United States $0.242B 0.00
ElectroCore (ECOR) United States $0.235B 0.00
Opexa Therapeutics (ACER) United States $0.235B 0.00
Galectin Therapeutics (GALT) United States $0.230B 0.00
Jounce Therapeutics (JNCE) United States $0.218B 0.00
Aldeyra Therapeutics (ALDX) United States $0.217B 0.00
MEI Pharma (MEIP) United States $0.214B 0.00
IMV INC (IMV) Canada $0.208B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.206B 0.00
Ardelyx (ARDX) United States $0.205B 0.00
Recro Pharma (REPH) United States $0.198B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.197B 0.00
Molecular Templates (MTEM) United States $0.195B 0.00
Nature's Sunshine Products (NATR) United States $0.194B 201.80
Aratana Therapeutics (PETX) United States $0.187B 0.00
Redhill Biopharma (RDHL) Israel $0.186B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.185B 0.00
Rafael Holdings (RFL) United States $0.182B 0.00
Ocular Therapeutix (OCUL) United States $0.174B 0.00
Aquestive Therapeutics (AQST) United States $0.172B 0.00
Neon Therapeutics (NTGN) United States $0.165B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.158B 0.00
China SXT Pharmaceuticals (SXTC) China $0.157B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.156B 0.00
AgeX Therapeutics (AGE) United States $0.150B 0.00
Cardiome Pharma (CORV) Canada $0.144B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.144B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.139B 0.00
MediWound (MDWD) Israel $0.138B 0.00
ProNAi Therapeutics (SRRA) Canada $0.138B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.124B 0.00
DURECT (DRRX) United States $0.122B 0.00
Champions Oncology (CSBR) United States $0.122B 0.00
Zafgen (ZFGN) United States $0.114B 0.00
Adherex Technologies (FENC) United States $0.113B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.113B 0.00
Infinity Pharmaceuticals (INFI) United States $0.102B 0.00
Nivalis Therapeutics (ALPN) United States $0.100B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.092B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.092B 0.00
India Globalization Capital (IGC) United States $0.089B 0.00
Otonomy (OTIC) United States $0.089B 0.00
Natural Alternatives (NAII) United States $0.085B 8.34
Genocea Biosciences (GNCA) United States $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.081B 0.00
SCYNEXIS (SCYX) United States $0.081B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.079B 0.00
Iterum Therapeutics (ITRM) Ireland $0.078B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.073B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.072B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.069B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.063B 0.00
Avenue Therapeutics (ATXI) United States $0.062B 0.00
CTI BioPharma (CTIC) United States $0.059B 0.00
Melinta Therapeutics (MLNT) United States $0.057B 0.00
Forward Pharma (FWP) Denmark $0.057B 0.00
Capnia (SLNO) United States $0.055B 0.00
KemPharm (KMPH) United States $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00
Lipocine (LPCN) United States $0.051B 0.00
BioLineRx (BLRX) Israel $0.047B 0.00
Mannatechorporated (MTEX) United States $0.043B 0.00
ProPhase Labs (PRPH) United States $0.039B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.037B 0.00
Achaogen (AKAO) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.033B 0.00
NOVAN INC (NOVN) United States $0.030B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
ContraFect (CFRX) United States $0.030B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.027B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
PharmAthene (ALT) United States $0.026B 0.00
IsoRay (ISR) United States $0.025B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Onconova Therapeutics (ONTX) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Can-Fite Biopharma (CANF) Israel $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.023B 0.00
Pain Therapeutics (PTIE) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.022B 0.00
Achieve Life Sciences (ACHV) United States $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
Xenetic Biosciences (XBIO) United States $0.020B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.020B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Shineco (TYHT) China $0.015B 2.54
Auris Medical Holding AG (EARS) Switzerland $0.014B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
VAXART, INC (VXRT) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.006B 0.00
Intellipharmaceutics (IPCI) Canada $0.005B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00